29542225|t|Memantine protects against ischemia/reperfusion-induced brain endothelial permeability.
29542225|a|Increased transendothelial permeability and subsequent blood-brain barrier damage play a key role in the pathological progression of human brain ischemia and secondary reperfusion. Memantine is a licensed drug providing clinically relevant efficacy in patients with Alzheimer's disease. However, little information is known regarding its effects on brain endothelial permeability. In this study, we investigated the effects of memantine on endothelial permeability and the underlying mechanisms in an ischemia-reperfusion (I/R) injury model in primary human brain microvascular endothelial cells. First, we found that memantine treatment prevented I/R-induced expression of tumor necrosis factor-alpha and interleukin-1beta at both the mRNA and the protein levels. Additionally, our results indicate that memantine treatment significantly reduced endothelial monolayer permeability after I/R by increasing the expression of tight junction protein occludin and the adherens junction protein VE-cadherin. In addition, we found that memantine reduced the expression and activity of matrix metalloproteinase (MMP)-2 but not MMP-9 after I/R. Memantine also elevated the expression of tissue inhibitors of metalloproteinase-2. Mechanistically, we found that memantine increased the expression of the transcriptional factor Krueppel-like factor 2 (KFL2) through activating extracellular signal regulated kinase (ERK5). In conclusion, our results identified a novel function of memantine in maintaining brain vascular barrier function and suggested that memantine might be a potential therapeutic agent for the treatment of stroke.   2018 IUBMB Life, 70(4):336-343, 2018.
29542225	0	9	Memantine	Chemical	MESH:D008559
29542225	27	35	ischemia	Disease	MESH:D007511
29542225	221	226	human	Species	9606
29542225	227	241	brain ischemia	Disease	MESH:D002545
29542225	269	278	Memantine	Chemical	MESH:D008559
29542225	340	348	patients	Species	9606
29542225	354	373	Alzheimer's disease	Disease	MESH:D000544
29542225	515	524	memantine	Chemical	MESH:D008559
29542225	589	609	ischemia-reperfusion	Disease	MESH:D015427
29542225	611	622	I/R) injury	Disease	MESH:D015427
29542225	640	645	human	Species	9606
29542225	706	715	memantine	Chemical	MESH:D008559
29542225	736	739	I/R	Disease	MESH:D015427
29542225	762	789	tumor necrosis factor-alpha	Gene	7124
29542225	794	811	interleukin-1beta	Gene	3553
29542225	893	902	memantine	Chemical	MESH:D008559
29542225	976	979	I/R	Disease	MESH:D015427
29542225	1035	1043	occludin	Gene	100506658
29542225	1078	1089	VE-cadherin	Gene	1003
29542225	1118	1127	memantine	Chemical	MESH:D008559
29542225	1167	1199	matrix metalloproteinase (MMP)-2	Gene	4313
29542225	1208	1213	MMP-9	Gene	4318
29542225	1220	1223	I/R	Disease	MESH:D015427
29542225	1225	1234	Memantine	Chemical	MESH:D008559
29542225	1340	1349	memantine	Chemical	MESH:D008559
29542225	1405	1427	Krueppel-like factor 2	Gene	10365
29542225	1493	1497	ERK5	Gene	5598
29542225	1558	1567	memantine	Chemical	MESH:D008559
29542225	1634	1643	memantine	Chemical	MESH:D008559
29542225	1704	1710	stroke	Disease	MESH:D020521
29542225	Positive_Correlation	MESH:D008559	1003
29542225	Negative_Correlation	MESH:D008559	MESH:D000544
29542225	Positive_Correlation	MESH:D008559	10365
29542225	Negative_Correlation	MESH:D008559	7124
29542225	Positive_Correlation	MESH:D015427	3553
29542225	Association	MESH:D015427	1003
29542225	Positive_Correlation	MESH:D015427	7124
29542225	Negative_Correlation	MESH:D008559	4313
29542225	Negative_Correlation	MESH:D008559	MESH:D015427
29542225	Association	MESH:D015427	100506658
29542225	Positive_Correlation	MESH:D008559	100506658
29542225	Negative_Correlation	MESH:D008559	MESH:D020521
29542225	Negative_Correlation	MESH:D008559	MESH:D007511
29542225	Negative_Correlation	MESH:D008559	3553
29542225	Positive_Correlation	MESH:D008559	5598

